Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
1(7%)
Results Posted
29%(2 trials)
Terminated
1(7%)

Phase Distribution

Ph not_applicable
15
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution15 total trials
N/ANon-phased studies
15(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

1

trials recruiting

Total Trials

15

all time

Status Distribution
Active(2)
Completed(7)
Terminated(1)
Other(5)

Detailed Status

Completed7
unknown5
Terminated1
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
1
Success Rate
87.5%
Most Advanced
N/A

Trials by Phase

N/A15 (100.0%)

Trials by Status

terminated17%
not_yet_recruiting17%
completed747%
unknown533%
recruiting17%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT07528404Not Applicable

High-Flow Nasal Cannula After Major Abdominal Surgery to Prevent Postoperative Pulmonary Complications

Not Yet Recruiting
NCT07059689Not Applicable

High-Flow Nasal Cannula vs. NIV After Extubation in Children Undergoing Heart Surgery

Recruiting
NCT05809089Not Applicable

HFNO in Pneumonia Patients Presenting With Acute Hypoxemic Respiratory Failure

Completed
NCT05499039Not Applicable

High Flow Nasal Cannula Versus Non-Invasive (NIV)in Both Hypoxemic and Hypercapnic Respiratory Failure.

Unknown
NCT05475119Not Applicable

Effect of High Flow Nasal Cannula Versus Continues Positive Airway Pressure in Adults With Obstructive Sleep Apnea

Unknown
NCT03816748Not Applicable

The Efficacy of Postoperative Application of HFNC at Acute Phase for Minimally Invasive Esophagectomy Surgery Patients

Completed
NCT04325906Not Applicable

Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS

Completed
NCT04715243Not Applicable

Comparison of High Flow Nasal Cannula (HFNC), Face-mask Non-Invasive Ventilation (NIV) & Helmet NIV in COVID-19 ARDS Patients

Terminated
NCT04741659Not Applicable

Tidal Volume in Patients With "de Novo" Acute Hypoxemic Respiratory Failure

Completed
NCT05075668Not Applicable

Efficacy of HFNC as an Alternative to CPAP Therapy in Surgical Patients With Suspected Moderate to Severe OSA

Completed
NCT04560257Not Applicable

High Flow Nasal Cannula HFNC In Covid-19 Patients

Unknown
NCT04619667Not Applicable

Effects of a New Interface for NIV on Respiratory Drive

Unknown
NCT04619641Not Applicable

Physiological Effects of a New Interface on Lung Ventilation and Gas Distribution

Unknown
NCT03615417Not Applicable

High-Flow Nasal Cannula (HFNC) Preoxygenation in Obese Patients Undergoing General Anesthesia

Completed
NCT02662387Not Applicable

External Nasal Dilator and Oxygen Therapy in Respiratory Failure

Completed

All 15 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
15